Clinical Trial Detail

NCT ID NCT01197170
Title Hormone Blockade in Combination With Targeted Agents
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Erlotinib

Everolimus

Sorafenib

Anastrozole

Bevacizumab

Age Groups: adult senior

Additional content available in CKB BOOST